NED PHARMA

Active

Private limited companyfounded 2025active for 1 yearChaussée de Maubeuge 274, 7022 Mons, BelgiumKBO/BCE: BE 1020.230.261

Summary

The computed 12-month bankruptcy probability of NED PHARMA is 2.2% (moderate). The 2025 annual accounts show equity of €23,080 and a net result of €20,080. Its solvency ranks better than 48% of 22,632 sector peers (NACE 47, financial year 2025). The company has been active since 2025 and the Belgian Official Gazette contains no insolvency or warning signals.

Risk analysisFollow Report Compare

NED PHARMAActiveChecked score 54/100

Risk analysis Report Compare

History

NED PHARMA was incorporated on 20 February 2025 as a private limited company by one natural person, with a starting capital of €3,000.¹² Since 2025, NDONGO ETOGO Désiré François has served as director of the company.² The company has filed annual accounts once, for financial year 2025.³

Acts, filings and financial milestones

All 2Gazette 1Filings 1

2026

31-08

NBB filing Annual accounts filed

financial year 2025 · micro format · 31 days late

2025

24-02

Gazette deed Incorporation

Appointment: NDONGO ETOGO Désiré François (director) · Founder · Founding capital11 facts ▸

Founder, NDONGO ETOGO Désiré François (comparant et fondateur unique)
Incorporation, “NED PHARMA” (deed in French)
Founding capital, €3,000
Bank account, “société en formation”, EUR (deed in French)
Other provision, “arrêt des statuts, arrêter les statuts de la société” (deed in French)
Capital
Other provision, “loi, Effectivité dispositions finales” (deed in French)
Registered office clause, “7022 Hyon,Chaussée de Maubeuge,274 bte 12” (deed in French)
Board rule, 1
Director appointment, NDONGO ETOGO Désiré François (director (not named in the articles))
Pre-incorporation commitments, “takeover, engagements,obligations en résultant,activités entreprises au nom et pour compte société en formation” (deed in French)

Gazette deedNBB filing

1 of 1 deed read